1. Home
  2. QMCO vs PEPG Comparison

QMCO vs PEPG Comparison

Compare QMCO & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum Corporation

QMCO

Quantum Corporation

HOLD

Current Price

$13.71

Market Cap

129.1M

Sector

Technology

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$1.83

Market Cap

121.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QMCO
PEPG
Founded
1980
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.1M
121.7M
IPO Year
2025
2022

Fundamental Metrics

Financial Performance
Metric
QMCO
PEPG
Price
$13.71
$1.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$10.50
$11.17
AVG Volume (30 Days)
1.6M
661.1K
Earning Date
02-17-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.61
EPS
N/A
N/A
Revenue
$372,827,000.00
N/A
Revenue This Year
$0.32
N/A
Revenue Next Year
$8.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.65
N/A
52 Week Low
$4.19
$1.01
52 Week High
$18.48
$7.80

Technical Indicators

Market Signals
Indicator
QMCO
PEPG
Relative Strength Index (RSI) 58.14 63.07
Support Level $5.93 $1.55
Resistance Level $15.33 $5.37
Average True Range (ATR) 2.36 0.10
MACD -0.04 0.07
Stochastic Oscillator 28.97 80.87

Price Performance

Historical Comparison
QMCO
PEPG

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Share on Social Networks: